Evidence map›Paper›PMID 9108931›Full record

ReviewTrends in microbiology1997

Problems and prospects of developing effective therapy for common cold viruses.

S L Johnston

Open access · greenAbstract readReview
In one paragraph

Review in Trends in microbiology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Efficacy and safety of Echinaforce® in respiratory tract infections.Wiener medizinische Wochenschrift (1946) · 2013
    Review
  2. Article
  3. Article
  4. Mechanisms of asthma exacerbation.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 1998
    Review
  5. Viruses and asthma.Allergy · 1998
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

S L JohnstonUniversity Medicine, Southampton General Hospital, UK. slj1@soton.ac.uk
Southampton General Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No effective treatment for common colds has yet been developed. Combination antiviral and anti-inflammatory therapies are the best hope for intervention after the onset of symptoms. Prophylaxis, especially in the form of vaccination, would have a major impact in disease prevention. These approaches offer new avenues for treating populations at risk and are of particular significance to those with asthma or chronic bronchitis.

Indexed as

Adrenal Cortex HormonesAnti-Inflammatory AgentsAntiviral AgentsCommon ColdCromolyn SodiumDrug DesignEpidemiologic FactorsHumansInflammationInterferonsOligonucleotides, AntisenseProtease InhibitorsVaccines, SyntheticAdrenal Cortex HormonesAnti-Inflammatory AgentsAntiviral AgentsCromolyn SodiumInterferonsOligonucleotides, AntisenseProtease InhibitorsVaccines, Synthetic

Identifiers

PMID9108931
PMCPMC7133329
OpenAlexW1983081563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.